Sage Mountain Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$999K Sell
1,086
-6,046
-85% -$6.13M 0.07% 92
2025
Q4
$7.66M Buy
7,132
+58
+0.8% +$55.5K 0.41% 38
2025
Q3
$5.4M Buy
7,074
+1,342
+23% +$999K 0.31% 47
2025
Q2
$4.47M Buy
5,732
+27
+0.5% +$21K 0.29% 44
2025
Q1
$4.71M Buy
5,705
+271
+5% +$225K 0.35% 41
2024
Q4
$4.19M Buy
5,434
+374
+7% +$310K 0.31% 45
2024
Q3
$4.48M Buy
5,060
+198
+4% +$178K 0.38% 37
2024
Q2
$4.4M Buy
4,862
+618
+15% +$494K 0.41% 35
2024
Q1
$3.3M Sell
4,244
-195
-4% -$139K 0.34% 40
2023
Q4
$2.59M Buy
4,439
+270
+6% +$158K 0.3% 49
2023
Q3
$2.24M Buy
4,169
+206
+5% +$106K 0.31% 44
2023
Q2
$1.86M Sell
3,963
-94
-2% -$39.4K 0.26% 51
2023
Q1
$1.39M Buy
4,057
+2,393
+144% +$807K 0.22% 54
2022
Q4
$609K Buy
1,664
+54
+3% +$19.1K 0.14% 60
2022
Q3
$521K Sell
1,610
-104
-6% -$33K 0.14% 64
2022
Q2
$556K Sell
1,714
-41
-2% -$12.3K 0.1% 201
2022
Q1
$503K Sell
1,755
-16
-0.9% -$4.12K 0.08% 258
2021
Q4
$489K Buy
1,771
+103
+6% +$26.1K 0.06% 313
2021
Q3
$385K Buy
1,668
+423
+34% +$104K 0.06% 305
2021
Q2
$286K Buy
1,245
+152
+14% +$30.5K 0.05% 324
2021
Q1
$204K Buy
+1,093
New +$214K 0.04% 297

Other funds holding LLY

Sage Mountain Advisors's LLY Position: Q1 2026 in Review

Sage Mountain Advisors reduced its Eli Lilly (LLY) stake by 85% in Q1 2026, selling an estimated $6.13M and leaving 1,086 shares worth $999K. The position accounts for 0.07% of the portfolio, ranked #92.

Sage Mountain Advisors first reported a position in LLY in Q1 2021 and has held it in 21 quarters since. The position peaked at $7.66M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Sage Mountain Advisors held 1,086 shares of Eli Lilly worth $999K as of Q1 2026.
  • Sage Mountain Advisors sold 6,046 Eli Lilly shares in Q1 2026, an estimated $6.13M.
  • Eli Lilly made up 0.07% of Sage Mountain Advisors's portfolio in Q1 2026, its #92 holding.
  • Sage Mountain Advisors first reported a position in Eli Lilly in Q1 2021 and has held it in 21 quarters since.
  • Sage Mountain Advisors's Eli Lilly position peaked at $7.66M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Sage Mountain Advisors's 13F filing for Q1 2026, filed 11 May 2026.